PCRX Pacira Corp: Operating Profitability

Public company logo of Pacira Corp (PCRX)

The EBIT margin reflects market expectations regarding the efficiency of Pacira BioSciences (PCRX). Strong physician confidence in Exparel and the ongoing fight against opioids strengthen the brand's position. The moderate use of external testers alongside in-house drug production optimizes costs, while the duplication of capacities by third-party plants eliminates shortages. The value of 4.20 determines this specific level of the operating profit parameter.

PCRX: Pacira Pharmaceuticals Operating Margin 07/04/2022 - 11/19/2026

Comprehensive metric breakdowns and analytics for Pacira BioSciences (PCRX)

- share price and consensus valuation forecast:
Initial company analysis:PCRX, pacira.com
Finished products of Pacira Corp

Operating margin measures the efficiency of profit generation from core business processes before accounting for debt service and taxes. This metric serves as a filter for stress-testing assets during periods of market volatility. By analyzing the operating margin chart, an investor determines the stability of operating cash flow. For Pacira BioSciences (PCRX), the stability of this indicator is supported by patent protection and the complexity of integrating drugs into hospital protocols. Such barriers limit competition, ensuring long-term pricing power.

Competitors of Pacira BioSciences

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.